Pavmed Inc. declined 2.63% in after-hours trading. The company's subsidiary, Veris Health, completed a private placement equity financing, yielding $2.5 million in proceeds. This news event is positive for the company as it provides additional capital, but the stock price movement suggests that investors may be reacting to other factors or the market sentiment.
Comments
No comments yet